About Us

Luye Pharma Group (02186.HK), a member of Luye Life Sciences Group, is an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications.

All Patients Enrolled for the Phase III Clinical Trial of Luye Pharma’s Ruoxinlin® for Treating Generalized Anxiety Disorder

News

Shanghai, August 18, 2025 –- Luye Pharma Group announced that all patients have been enrolled for a Phase 3 clinical trial of its Ruoxinlin® (Toludesvenlafaxine Hydrochloride Sustained-Release Tablets) designated as a Class 1 ...

August 18,2025

First Subject Enrolled in Phase 1 Clinical Trial for Luye Pharma’s Investigational Antidepressant Targeting NET/DAT/GABAAR

Shanghai, August 3, 2025 -- Luye Pharma Group today announced that the first subject has been enrolled in a Phase 1 clinical trial in China for its LY03021, which was filed through China’s Class 1 pathway for innovative drugs. LY03021 is an ...

August 03,2025

Read More

Investors

Employee Stories

Upholding the philosophy of “Employee Development”,
Luye Pharma regards employees as the most valuable resources of the company